AANEM News Express

AANEM News Express

Science News: Individualized Immunoglobulin Therapy in Chronic Immune-Mediated Peripheral Neuropathies

10/2/2018
 
Submitted by Benn E. Smith, MD, News Science Editorial Board
Edited by Leigh Maria K. Ramos-Platt, MD, News Science Editorial Board


Allen JA, et al. Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathies. J Peripher Nerv Syst 2018;00:1-10.

This is the written manuscript by Allen and colleagues (an international cohort of peripheral nerve experts) on IVIg therapy utilization immune-mediated peripheral neuropathy. This review is based on a symposium presented at the 2017 Peripheral Nerve Society meeting in Sitges, Spain. The review is well-structured, beginning with a clear presentation of IVIg immunology, biology and pharmacokinetics, followed by a cogent discussion of the well-known “wearing off” phenomenon and the finally a recommended algorithm to be used to adjust frequency and dose adjustments in individual patients with neuropathies for which IVIg is given. 

Comment: This practical review will be of keen interest to all in the readership of Muscle & Nerve who use IVIg for immune neuropathies.


View Related News Stories:

  EducationScience News


Recent AANEM News

Science News: Peripheral Nerve Regeneration Using a Bio 3D Conduit from Undifferentiated Bone Marrow Stromal Cells

2018 Anthology of Articles from the News Science Editorial Board Now Available

Science News: Low Sensitivity of Skin Biopsy in Diagnosing Small Fiber Neuropathy in Chinese Americans

Science News: A Novel Autoantibody Against Plexin D1 in Patients with Neuropathic Pain

Science News: Randomized Double-blinded Clinical Trial of 5% Dextrose Versus Triamcinolone Injection for Carpal Tunnel Syndrome Patients





Advertisement

TPP

Advertisement

ABEM

Advertisement

Find Your Dream Job